Skip to content

13F-HR filed by Krensavage Asset Management, LLC

Krensavage Asset Management, LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-15, with 10 holding rows worth $288,314,000.

Accession
0001609251-22-000002
Filed
2022-02-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 10 entries on the cover page, a total value of $288,314,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $288,314,000 with VALUE read as thousands by filing date, 13F file number 028-16807. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
UNITED THERAPEUTICS CORP DEL COM91307C102Stock204,812$44,256,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock69,080$43,625,000thousands by filing date
ENANTA PHARMACEUTICALS INC29251M106COM564,102$42,184,000thousands by filing date
MCKESSON CORP COM58155Q103Stock156,424$38,882,000thousands by filing date
ALKERMES PLCG01767105SHS1,442,965$33,563,000thousands by filing date
EXELIXIS INC COM30161Q104Stock1,557,119$28,464,000thousands by filing date
TARO PHARMACEUTICAL INDS LTDM8737E108SHS538,967$27,008,000thousands by filing date
BIOGEN INC COM09062X103Stock103,053$24,724,000thousands by filing date
EAGLE PHARMACEUTICALS INC269796108COM106,487$5,422,000thousands by filing date
NEXTCURE INC65343E108COM31,027$186,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001609251-22-000002this filing2022-02-15acceptance time not in the bulk data set